Table 3. Clostridium difficile infection outcome among the study group. Values are presented as number (%), or p-value.

Outcome	Age range (frequency) (yr) (n)	CDI in patients on steroids (n=10)	CDI in patients not on steroids (n=4)	P-value (Fisher’s exact test)
Treatment n (%)
Vancomycin	50-65 (3)	4 (28,6%)	3 (21,4%)	0.55
Metronidazole	<50 (5)	8 (57,1%)	3 (21,4%)	1.00
Fidaxomicin	>65 (2)	2 (14,3%)	0 (0,0%)	1.00
Biologics n (%)
Infliximab	50-65, >65 (1)	2 (14,3%)	1 (7,1%)	1.00
Golimumab	<50 (2)	3 (21,4%)	0 (0,0%)	0.50
Recurrence n (%)	50-65 (1)	1 (7,1%)	0 (0,0%)	1.00
Colectomy n (%)	>50 (4)	4 (28,6%)	0 (0,0%)	0.25